TVRD

Tvardi Therapeutics
TVRD

Overview Fund Trends Analyst Outlook Journalist POV

97 hedge funds and large institutions have $21.7M invested in Tvardi Therapeutics in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 33 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

27% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 33

52% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 23

Holders
97
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$46K
Puts
$4K
Net Calls
Net Calls Change

Top Buyers

1
+$1.41M
2
+$578K
3
+$466K
4
Stifel Financial
Stifel Financial
Missouri
+$390K
5
Millennium Management
Millennium Management
New York
+$177K

Top Sellers

1
-$746K
2
-$727K
3
-$518K
4
Morgan Stanley
Morgan Stanley
New York
-$437K
5
GCP
GSA Capital Partners
United Kingdom
-$163K
Name Holding Trade Value Shares
Change 		Change in
Stake
101
–
102
–
103
–
104
–
105
–
106
–
107
–
108
–
109
–
110
–
111
–
112
–
113
–
114
–
115
–
116
–
117
–
118
–
119
–
120
–
121
–
122
–
123
–
124
–
1 2 3 4
5